Multiple Myeloma Medications
Here's a list of the approved drugs to treat multiple myeloma. Click on any of the medications for more info on indications, dosing and side effects.
Quick Filter
*generic version available
E experimental
Chemotherapy Medications
Immunotherapy Medications
Targeted Therapy Medications
Chemotherapy Medications More >>
DRUG Chemotherapy |
---|
GENERIC NAME Multiple |
DRUG INDICATION
Cytotoxic chemotherapy, the oldest and most commonly used type of cancer treatment, halts cell division and kills rapidly growing cells. For a full list of chemotherapy drugs, click here. |
DRUG Farydak |
---|
GENERIC NAME panobinostat |
DRUG INDICATION
Farydak is an HDAC inhibitor approved for multiple myeloma, in combination with dexamethasone and Velcade (bortezomib). |
DRUG Xpovio |
---|
GENERIC NAME selinexor |
DRUG INDICATION
Xpovio is the first approved nuclear export inhibitor. It is indicated for people with previously treated relapsed or refractory (nonresponsive) multiple myeloma or diffuse large B-cell lymphoma. |
Immunotherapy Medications More >>
DRUG Pomalyst |
---|
GENERIC NAME pomalidomide |
DRUG INDICATION
Pomalyst is an immunomodulator approved for multiple myeloma and Kaposi sarcoma. |
DRUG Revlimid |
---|
GENERIC NAME lenalidomide |
DRUG INDICATION
Revlimid is an immunomodulator approved for multiple myeloma in combination with dexamethasone, for follicular lymphoma and marginal zone lymphomain in combination with Rituxan (rituximab), and as a single drug for myelodysplastic syndromes and mantle cell lymphoma. |
DRUG Thalomid |
---|
GENERIC NAME thalidomide |
DRUG INDICATION
Thalomid is an immunomodulator approved for multiple myeloma, in combination with dexamethasone. |
Targeted Therapy Medications More >>
DRUG Blenrep |
---|
GENERIC NAME belantamab mafodotin |
DRUG INDICATION
Blenrep is a BCMA-directed antibody-drug conjugate approved for people with heavily pretreated relapsed or refractory multiple myeloma. |
DRUG Darzalex, Darzalex Faspro |
---|
GENERIC NAME daratumumab |
DRUG INDICATION
Darzalex is a CD38 inhibitor approved for newly diagnosed or previously multiple myeloma, in combination with various other medications. Darzalex Faspro is a newer formulation that can be given by subcutaneous injection rather than IV infusion. |
DRUG Empliciti |
---|
GENERIC NAME elotuzumab |
DRUG INDICATION
Empliciti is a SLAMF7 inhibtor approved multiple myeloma, in combination with dexamethasone and Revlimid (lenalidomide). |
DRUG Kyprolis |
---|
GENERIC NAME carfilzomib |
DRUG INDICATION
Kyprolis is a proteasome inhibitor approved for relapsed or refractory multiple myeloma, used alone or in combination with other medications. |
DRUG Ninlaro |
---|
GENERIC NAME ixazomib |
DRUG INDICATION
Ninlaro is a proteasome inhibitor approved multiple myeloma, in combination with dexamethasone and Revlimid (lenalidomide). |
DRUG Sarclisa |
---|
GENERIC NAME isatuximab-irfc |
DRUG INDICATION
Sarclisa is a CD38 inhibitor approved for combination treatment of multiple myeloma in previously treated people. |
DRUG Velcade |
---|
GENERIC NAME bortezomib |
DRUG INDICATION
Velcade is a proteasome inhibitor approved for multiple myeloma and mantle cell lymphoma. |